Quarterly report · Q3
3154.TEDINET S100QPVK
Period2022-07-01 → 2023-03-31
Filed2023-05-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Amended by S100RJV8 (2023-08-14).
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥177.5bn | 2022-07-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥221.7bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥169.9bn | 2021-07-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥2.4bn | 2022-07-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥3.3bn | 2021-07-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥2.8bn | 2022-07-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.7bn | 2021-07-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.9bn | 2022-07-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.6bn | 2021-07-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.8bn | 2022-07-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.9bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.5bn | 2021-07-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.8bn | 2022-07-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥2.5bn | 2021-07-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥105.8bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥93.0bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥100.5bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥87.4bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥75.6bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥18.4bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥17.3bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥17.7bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.1bn | at 2022-06-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥81.92 | 2022-07-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.72 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.3 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.21 | 2021-07-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.81 | 2022-01-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥81.67 | 2022-07-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥85.15 | 2021-07-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥116.11 | 2021-07-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 17.4% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.6% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2023-03-31 | −¥176,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2023-03-31 | −¥176,000 |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2023-03-31 | −¥5.5bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥173.4bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥173.4bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥176,000 |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥7.5bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥315m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2023-03-31 | ¥177.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2023-03-31 | ¥177.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥176,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2023-03-31 | ¥7.9bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-03-31 | −¥5.0bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥165.9bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥165.9bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥7.9bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥406m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2022-03-31 | ¥169.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2022-03-31 | ¥169.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2022-03-31 | ¥8.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 378
| Item | Context | Value | Unit |
|---|---|---|---|
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03-6811-2958(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役専務執行役員 経営管理統括本部長 芥 川 浩 之 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E22995 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 31540 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)メディアスホールディングス株式会社 | |
| Filer name in english | FilingDateInstant | MEDIUS HOLDINGS Co.,Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2022-07-01 | |
| Current period end date | FilingDateInstant | 2023-03-31 | |
| Type of current period | FilingDateInstant | Q3 | |
| Current fiscal year end date | FilingDateInstant | 2023-06-30 | |
| Previous fiscal year start date | FilingDateInstant | 2021-07-01 | |
| Comparative period end date | FilingDateInstant | 2022-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2022-06-30 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所プライム市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |